Description

Atorvastatin calcium is a widely studied statin-class compound that acts as an HMG-CoA reductase inhibitor, effectively reducing the biosynthesis of cholesterol in the liver. It is used in experimental models of hyperlipidemia, atherosclerosis, and cardiovascular risk profiling.

This product contains 20mg atorvastatin calcium per tablet, supplied in a box of 9 tablets. Suitable for research on lipid-lowering pharmacology, endothelial function, and anti-inflammatory properties of statins.

Manufactured by Beijing Jingfeng Pharmaceutical Group Co., Ltd. under Baolong Pharma brand. China NMPA approval number: H20213200. Product code: 86900151001089.

?? For laboratory research use only. Not for human or veterinary use.

Product Specifications

Mechanism & Research Applications

Atorvastatin works by competitively inhibiting HMG-CoA reductase, the rate-limiting enzyme in the biosynthesis of cholesterol. This leads to reduced cholesterol production and an increase in hepatic LDL receptor expression, promoting LDL clearance.

In laboratory settings, it is used for:

• Investigating cholesterol metabolism and lipid regulation

• Studying cardiovascular disease models and plaque formation

• Exploring statin-induced endothelial effects and anti-inflammatory responses

• Assessing drug interaction profiles in lipid-lowering therapies

Safety & Handling

• Use Restriction: For laboratory research only

• PPE Required: Gloves, safety glasses, lab coat

• Storage: Store sealed below 25°C, away from moisture and direct sunlight

• Disposal: Follow institutional protocols for chemical waste

Research Use Disclaimer

This product is intended strictly for laboratory research and not approved for clinical, diagnostic, or veterinary use. Misuse may involve health or legal risks. Always follow institutional biosafety and regulatory guidelines.